↓ Skip to main content

American Association for Cancer Research

A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors

Overview of attention for article published in Clinical Cancer Research, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#19 of 12,991)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
61 news outlets
twitter
6 X users

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
45 Mendeley
Title
A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors
Published in
Clinical Cancer Research, April 2019
DOI 10.1158/1078-0432.ccr-18-1337
Pubmed ID
Authors

Eric Van Cutsem, Boguslawa Karaszewska, Yoon-Koo Kang, Hyun Cheol Chung, Veena Shankaran, Salvatore Siena, Ning F. Go, Hui Yang, Marco Schupp, David Cunningham

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 24%
Student > Ph. D. Student 7 16%
Student > Master 4 9%
Student > Postgraduate 3 7%
Other 3 7%
Other 6 13%
Unknown 11 24%
Readers by discipline Count As %
Medicine and Dentistry 14 31%
Biochemistry, Genetics and Molecular Biology 5 11%
Agricultural and Biological Sciences 2 4%
Nursing and Health Professions 2 4%
Chemistry 2 4%
Other 4 9%
Unknown 16 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 431. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2023.
All research outputs
#61,435
of 24,344,498 outputs
Outputs from Clinical Cancer Research
#19
of 12,991 outputs
Outputs of similar age
#1,234
of 355,260 outputs
Outputs of similar age from Clinical Cancer Research
#1
of 201 outputs
Altmetric has tracked 24,344,498 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,991 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,260 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.